General Information
NovMeta Pharma DM 002
A Multicenter, Randomized, Double-Blind, Placebo-controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Cyclo-Z in Subjects with Type 2 Diabetes
| Protocol | NMP-CYZ-P2-002 |
|---|---|
| Identifier | |
| UID | c1ed16bc-c8c8-49ab-94d4-110b24e2a215 |
| Status | Done - Archived |
| Phase | 2 |
| Category | Diabetes Type 2 / Adult |
| Launch Year | 2018 |
| NCT Number | - |
| Created | 2018-04-25 10:09 |
| Last Updated | 2018-04-25 10:09 |
Description
No description provided.
Comment
CRI
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | 2018-12-19 | No |
| Enrollment Open | 2018-06-28 | No |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2018-06-18 | No |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2019-09-24 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Mohseni, Rizwana | RMohseni | No |
| Recruiter | - | No | |
| Coordinator | Pereira, Cynthia | CPereira | No |
| Regulatory | - | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | NovMeta Pharma Co., Ltd. |
|---|---|
| Division | NovMeta Pharma Co., Ltd. |
| Team | NovMeta Pharma Co., Ltd. |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | InClin, Inc. |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
